{"gene":"PF3D7_1407800","run_date":"2026-09-08T14:19:07","timeline":{"discoveries":[{"year":2002,"finding":"PM4 (PF3D7_1407800) is expressed during the hemoglobin-degrading intraerythrocytic stage and its protein product localizes to the food vacuole of P. falciparum, where it functions as one of four active hemoglobin-degrading aspartic proteases (alongside PM I, PM II, and HAP).","method":"Genome-wide expression analysis, food vacuole fractionation, functional enzymatic assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct subcellular fractionation combined with enzymatic activity assays; replicated by multiple subsequent studies","pmids":["11782538"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2002,"finding":"Recombinant PM4 hydrolyzes human hemoglobin at the primary cleavage site known to initiate the hemoglobin degradation pathway, and its activity is inhibited in vitro by synthetic peptidomimetic inhibitors that also block parasite growth in red blood cell culture.","method":"In vitro enzyme activity assay with native and denatured hemoglobin substrate; inhibitor Ki measurement","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro enzymatic reconstitution with substrate and inhibitor characterization in a single focused study","pmids":["11904142"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2003,"finding":"PM4 from P. falciparum and its orthologs from other Plasmodium species (P. vivax, P. knowlesi, P. berghei, P. yoelii, P. ovale, P. malariae) all localize to purified food vacuole preparations; PM4 is the sole food-vacuole plasmepsin in non-falciparum species, whereas P. falciparum has three paralogs (PM1, PM2, HAP) in addition to PM4. Localization was confirmed by 2D gel electrophoresis and mass spectrometry of purified food vacuole fractions.","method":"Two-dimensional gel electrophoresis and mass spectrometry of purified food vacuole preparations; genomic DNA blot analysis","journal":"Molecular and biochemical parasitology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct fractionation with orthogonal proteomics identification, multi-species confirmation","pmids":["14550891"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""},{"species":"Plasmodium vivax","strain":""},{"species":"Plasmodium knowlesi","strain":""},{"species":"Plasmodium berghei","strain":""},{"species":"Plasmodium yoelii","strain":""},{"species":"Plasmodium ovale","strain":""},{"species":"Plasmodium malariae","strain":""}]},{"year":2003,"finding":"A designed adaptive inhibitor targeting the plasmepsin family inhibits PM4 with a Ki of ~0.2 nM (Ki ratio relative to PM II = 0.4), demonstrating that PM4's active site can accommodate the allophenylnorstatine scaffold with near-equal or greater potency than PM II.","method":"In vitro enzyme inhibition assay (Ki measurement); isothermal titration calorimetry","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous in vitro binding and inhibition assay, single study","pmids":["12859191"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2004,"finding":"Genetic disruption of pfpm4 in P. falciparum is achievable (gene is not essential), but Δpfpm4 parasites show a reduced growth rate and a statistically significant reduction in hemozoin accumulation per parasite, indicating impaired hemoglobin digestion. An accumulation of electron-dense vesicles in the digestive vacuole was also observed in ~one-third of disrupted cells.","method":"Gene knockout by homologous recombination; PCR, Southern, Northern, Western blot confirmation; growth rate measurement; hemozoin quantification; electron microscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean gene disruption confirmed by multiple molecular methods, specific cellular phenotype readouts, replicated in subsequent studies","pmids":["15491999"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"Dd2"}]},{"year":2006,"finding":"Loss of all four digestive vacuole plasmepsins (including PM4) in a quadruple-PM knockout results in slower growth, delayed schizont maturation, reduced hemozoin formation, accumulation of multilamellar ceroid-like bodies in the digestive vacuole, and accumulation of autophagic intermediates, establishing that PM4 contributes (along with PM1, PM2, HAP) to degradation of endosomal vesicles delivered to the digestive vacuole.","method":"Double-crossover chromosomal deletion knockout; growth assays; electron microscopy; Western blot for autophagic markers; hemozoin measurement","journal":"Molecular microbiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — quadruple KO with multiple orthogonal phenotypic readouts, clearly implicating PM4 as part of the DV protease ensemble","pmids":["17581121"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"3D7"}]},{"year":2006,"finding":"Crystal structure of PM4 from P. falciparum complexed with inhibitors was used (via homology model and molecular dynamics) to define the binding pocket geometry; key variable regions distinguishing PM4 from PM II were identified, and a symmetric oxadiazole-containing inhibitor was identified as the most potent PM4 binder.","method":"Crystal structure determination; molecular dynamics simulation; linear interaction energy (LIE) calculations; in vitro Ki measurement","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — structural and MD data with experimental Ki validation, single study; homology model rather than de novo PM4 crystal structure used","pmids":["16939205"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2006,"finding":"Δpfpm4 single-knockout parasites (but not Δpfpm1 or Δpfpm2 single-knockouts) show a statistically significant reduction in hemozoin accumulation per parasite cycle, establishing PM4 as the individual digestive vacuole plasmepsin with the greatest contribution to hemoglobin digestion among the four. No compensatory upregulation of paralogous plasmepsin mRNAs or proteins was detected in any single-KO.","method":"Gene disruption; hemozoin quantification; Northern blot; Western blot for paralogous plasmepsins","journal":"International journal for parasitology","confidence":"High","confidence_rationale":"Tier 2 / Strong — targeted gene disruption with specific quantitative phenotype, confirmed at both mRNA and protein level, multiple KO lines compared","pmids":["17207486"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":"Dd2"}]},{"year":2009,"finding":"Deletion of pm4 in Plasmodium berghei significantly reduces asexual blood-stage growth rate and prevents induction of experimental cerebral malaria (ECM) in susceptible mice; Δpm4 P. berghei parasites induce strong protective immunity lasting at least one year.","method":"Gene knockout in P. berghei; in vivo mouse infection experiments; real-time in vivo parasite imaging; splenectomy experiments; antibody-depletion assays","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean gene disruption with multiple in vivo phenotypic readouts and mechanistic dissection of immunity mechanism","pmids":["20019192"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2010,"finding":"In Plasmodium gallinaceum, the PM4 ortholog (PgPM4) is secreted by ookinetes and localizes to the ookinete apical surface and micronemes (not only the digestive vacuole); anti-PgPM4 monoclonal antibodies and aspartic protease inhibitors significantly reduce parasite infectivity for mosquitoes, implicating PM4 in ookinete invasion of the mosquito midgut.","method":"De novo mass spectrometry sequencing of benzamidine affinity column eluate; immunolocalization; infectivity assays with monoclonal antibodies and inhibitors","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — MS identification plus immunolocalization plus functional inhibition assays in a single study; performed in P. gallinaceum, not P. falciparum","pmids":["20056606"],"is_preprint":false,"attribution":[{"species":"Plasmodium gallinaceum","strain":""}]},{"year":2011,"finding":"Recombinant P. vivax PM4 (PvPM4) undergoes autocatalytic maturation under acidic conditions in a pepstatin A-sensitive manner, requires a portion of the prodomain for correct folding, hydrolyzes native and denatured hemoglobin at acidic pH, and acts synergistically with vivapains (cysteine proteases) in hemoglobin hydrolysis; vivapains also mediate processing of PvPM4 into its mature form.","method":"Recombinant protein expression, refolding, and autocatalytic maturation assay; hemoglobin hydrolysis assay; synergy assay with vivapain-2 and vivapain-3; pepstatin A inhibition","journal":"Experimental parasitology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution of enzymatic activity, maturation, and synergy with multiple orthogonal assays in a single study","pmids":["21334328"],"is_preprint":false,"attribution":[{"species":"Plasmodium vivax","strain":""}]},{"year":2011,"finding":"Sequential disruption of both pm4 and msp7 in P. berghei produces a synergistically virulence-attenuated phenotype (self-resolving infection, low parasitemia, no ECM) greater than either single-gene deletion alone, and convalescent mice are protected against challenge with P. berghei or P. yoelii.","method":"Sequential gene disruption; in vivo mouse infection; parasitemia monitoring; cross-species challenge experiments","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis experiment demonstrating additive/synergistic effect of pm4 and msp7 deletions, single lab","pmids":["22355558"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2013,"finding":"PM4 is a component of an approximately 200-kDa protein complex in the food vacuole that also contains falcipain 2/2', plasmepsin II, histo-aspartic protease, and heme detoxification protein (HDP); this complex is required for hemoglobin degradation and hemozoin formation.","method":"Co-immunoprecipitation followed by mass spectrometry; gel filtration co-elution; glycerol gradient cosedimentation; in vitro protein interaction analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — four orthogonal biochemical methods (Co-IP/MS, gel filtration, glycerol gradient, in vitro interaction) establishing complex membership","pmids":["23471987"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2015,"finding":"Recombinant P. berghei PM4 (PbPM4) zymogen expressed in E. coli undergoes auto-maturation at pH 4.5–5.5 and, unusually, retains catalytic activity even in the presence of the pro-segment. Active site subsite preferences (S1, S2, S3, S1', S2', S3') were mapped using combinatorial peptide libraries, enabling design of a peptidomimetic inhibitor with >10-fold selectivity for PM4 orthologs over human cathepsin D.","method":"Recombinant protein expression, in vitro refolding, auto-maturation assay; combinatorial peptide library substrate profiling; enzyme kinetics; inhibitor Ki measurement","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with active-site mapping by combinatorial chemistry and inhibitor design/validation, multiple orthogonal assays in one study","pmids":["26510189"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2016,"finding":"Crystal structure of truncated zymogen of PM4 from P. falciparum (pPM IV, consisting of mature enzyme plus a 47-residue prosegment) was determined at 1.5 Å resolution, revealing the characteristic bi-lobed aspartic protease fold and showing greater structural similarity to proplasmepsin IV from P. vivax than to the other two P. falciparum proplasmepsins (proplasmepsin I and proplasmepsin II).","method":"X-ray crystallography at 1.5 Å resolution","journal":"Acta crystallographica. Section F, Structural biology communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — high-resolution crystal structure, single study but direct structural determination of the query gene product","pmids":["27599854"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"finding":"KNI peptidomimetic inhibitors (KNI-10742, 10743, 10395, 10333, 10343) inhibit PM4 (PMIV) activity with low-nanomolar Ki values. High-resolution crystal structures of PMII-KNI inhibitor complexes (used as structural surrogates to model PMIV interactions) reveal specific contacts (Asp132, Leu133, Ser134; P2/P2' positioning) that modulate differential potency across vacuolar plasmepsins.","method":"In vitro Ki measurement against PM IV; crystal structures of PMII-KNI complexes at high resolution (PDB: 5YIE, 5YIB, 5YID, 5YIC, 5YIA); cellular Hb-degradation blockade assay","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — crystal structures and Ki data for PMII used to rationalize PMIV inhibition; PMIV structures not independently solved here, single lab","pmids":["29943906"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"finding":"In P. berghei, deletion of PM4 (but not PM7 or PM8) significantly reduces susceptibility to lopinavir and saquinavir (retroviral protease inhibitors) in a 4-day suppressive in vivo test, suggesting PM4 mediates at least part of the antimalarial action of these compounds.","method":"Gene knockout in P. berghei; 4-day in vivo suppressive test with lopinavir/ritonavir and saquinavir/ritonavir; molecular docking of inhibitors to PM4","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genetic epistasis (KO reduced drug sensitivity) with molecular docking support, single lab, single study","pmids":["30067811"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":"ANKA"}]},{"year":2020,"finding":"Vacuolar plasmepsin zymogens (pro-tPMs, including the PM4-family) inherently form S-shaped dimers; under acidic conditions, disruption of the Tyr-Asp loop (121p-4), coupled with movement of loop L1 (237-247) and helix H2 (101p-113p), extends the pro-mature region containing the cleavage site, dissociates dimers to monomers, and allows prosegment unfolding so that the active site becomes accessible. One monomer then cleaves the prosegment of the other via a novel trans-activation mechanism, generating mature enzyme that drives complete conversion of remaining zymogens.","method":"X-ray crystallography (PDB: 6KUB, 6KUC, 6KUD); molecular dynamics simulations; biochemical activation assays","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple crystal structures combined with MD simulations and biochemical validation of activation mechanism in a single rigorous study","pmids":["32385863"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"PM4 (PF3D7_1407800) is an aspartic protease that is synthesized as an inactive zymogen, trafficked to the food vacuole where it undergoes acid-triggered trans-activation via an S-shaped dimer intermediate, and then functions as a hemoglobinase within a ~200-kDa multi-enzyme complex (with falcipain 2/2', PM II, HAP, and HDP) that drives hemoglobin degradation and hemozoin formation; it is the individual digestive vacuole plasmepsin that contributes most to hemozoin accumulation, and in sexual/mosquito stages its ortholog additionally localizes to ookinete micronemes and the apical surface where it participates in midgut invasion."},"narrative":{"mechanistic_narrative":"PM4 (PF3D7_1407800) is a food-vacuole aspartic protease that initiates and drives the intraerythrocytic hemoglobin degradation pathway of Plasmodium and thereby feeds hemozoin formation [PMID:11782538, PMID:11904142]. It is expressed during the hemoglobin-degrading blood stage and localizes to the food vacuole, where it acts as one of four active hemoglobinase plasmepsins in P. falciparum (with PM1, PM2, and HAP) but is the sole food-vacuole plasmepsin in other Plasmodium species [PMID:11782538, PMID:14550891]. Recombinant PM4 hydrolyzes native and denatured hemoglobin, including cleavage at the site that initiates hemoglobin catabolism, and its activity is blocked by peptidomimetic inhibitors that also arrest parasite growth [PMID:11904142, PMID:21334328]. PM4 is synthesized as a zymogen that undergoes acid-triggered maturation: vacuolar plasmepsin pro-forms assemble into S-shaped dimers, and under acidic pH conformational changes at the Tyr-Asp loop, loop L1, and helix H2 dissociate the dimer and expose the cleavage site so that one monomer trans-activates the prosegment of the other [PMID:32385863, PMID:27599854]. Once mature, PM4 operates within an ~200-kDa food-vacuole complex containing falcipain 2/2', PM2, HAP, and the heme detoxification protein HDP that couples hemoglobin proteolysis to hemozoin formation [PMID:23471987]. Genetic disruption studies establish PM4 as functionally important but non-essential: Δpfpm4 parasites grow more slowly and, among the single food-vacuole plasmepsin knockouts, show the greatest reduction in hemozoin accumulation without compensatory paralog upregulation [PMID:15491999, PMID:17207486]. In P. berghei, pm4 deletion attenuates blood-stage growth and prevents experimental cerebral malaria while conferring protective immunity [PMID:20019192], and in the avian parasite P. gallinaceum the PM4 ortholog additionally localizes to ookinete micronemes and the apical surface and participates in mosquito midgut invasion [PMID:20056606].","teleology":[{"year":2002,"claim":"Establishing where PM4 acts and what it does answered whether it is a bona fide hemoglobinase rather than merely a plasmepsin family member.","evidence":"Genome-wide expression, food-vacuole fractionation, and enzymatic assays in P. falciparum, plus recombinant hemoglobin hydrolysis and inhibitor assays","pmids":["11782538","11904142"],"confidence":"High","gaps":["Relative contribution of PM4 versus the other three vacuolar plasmepsins not yet quantified","In vivo cleavage kinetics on intact hemoglobin within the vacuole not resolved"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2003,"claim":"Cross-species localization defined PM4 as the conserved core food-vacuole plasmepsin, showing that non-falciparum species rely on PM4 alone whereas P. falciparum has paralog redundancy.","evidence":"2D gel electrophoresis and mass spectrometry of purified food-vacuole fractions across seven Plasmodium species; genomic DNA blot","pmids":["14550891"],"confidence":"High","gaps":["Functional consequence of single- versus multi-plasmepsin architecture not tested here","Does not address complex membership or maturation"],"attribution":[{"species":"Plasmodium falciparum","strain":""},{"species":"Plasmodium vivax","strain":""},{"species":"Plasmodium knowlesi","strain":""},{"species":"Plasmodium berghei","strain":""},{"species":"Plasmodium yoelii","strain":""},{"species":"Plasmodium ovale","strain":""},{"species":"Plasmodium malariae","strain":""}]},{"year":2004,"claim":"Gene disruption tested whether PM4 is essential and revealed a specific hemoglobin-digestion phenotype rather than lethality.","evidence":"Homologous-recombination knockout in P. falciparum Dd2 with growth, hemozoin, and EM readouts","pmids":["15491999"],"confidence":"High","gaps":["Cannot exclude partial compensation by paralogs","Molecular basis of the electron-dense vesicle accumulation unresolved"],"attribution":[{"species":"Plasmodium falciparum","strain":"Dd2"}]},{"year":2006,"claim":"Comparing single- and quadruple-knockouts ranked PM4 as the dominant individual vacuolar plasmepsin for hemozoin production and showed the ensemble also processes endosomal cargo.","evidence":"Single and quadruple plasmepsin knockouts in P. falciparum with hemozoin quantification, Northern/Western for paralogs, EM and autophagic markers","pmids":["17581121","17207486"],"confidence":"High","gaps":["Mechanism by which PM4 loss reduces hemozoin more than other paralogs not defined","No compensatory upregulation seen, but functional overlap during infection not measured"],"attribution":[{"species":"Plasmodium falciparum","strain":"3D7"},{"species":"Plasmodium falciparum","strain":"Dd2"}]},{"year":2006,"claim":"Structural and inhibitor-binding characterization began to define PM4's active-site geometry and the features distinguishing it from PM2 for selective drug design.","evidence":"Crystal structure/homology model with molecular dynamics, LIE calculations, and in vitro Ki measurements","pmids":["16939205","12859191"],"confidence":"Medium","gaps":["Relied partly on homology modeling rather than de novo PM4 structure","Selectivity over host aspartic proteases not established here"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"claim":"Discovery of a secreted, apically localized PM4 in ookinetes extended its role beyond the food vacuole to mosquito-stage invasion.","evidence":"De novo MS sequencing, immunolocalization, and infectivity blockade with monoclonal antibodies and inhibitors in P. gallinaceum","pmids":["20056606"],"confidence":"Medium","gaps":["Shown in P. gallinaceum, not P. falciparum","Molecular substrate mediating midgut invasion not identified"],"attribution":[{"species":"Plasmodium gallinaceum","strain":""}]},{"year":2011,"claim":"Reconstitution of recombinant PM4 established acid-triggered autocatalytic maturation and cooperative hemoglobin digestion with cysteine proteases.","evidence":"Recombinant expression, refolding, autocatalytic maturation, hemoglobin hydrolysis, and synergy assays with vivapains in P. vivax","pmids":["21334328"],"confidence":"High","gaps":["Structural intermediate of maturation not resolved in this study","In vivo relevance of vivapain-mediated PM4 processing not tested"],"attribution":[{"species":"Plasmodium vivax","strain":""}]},{"year":2011,"claim":"Genetic epistasis with msp7 in P. berghei defined PM4 as a virulence determinant whose loss can be combined to attenuate infection and elicit cross-protective immunity.","evidence":"Sequential gene disruption, in vivo parasitemia monitoring, and cross-species challenge in P. berghei","pmids":["22355558","20019192"],"confidence":"Medium","gaps":["Mechanistic link between PM4 loss and reduced virulence not molecularly defined","Single-lab in vivo studies"],"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2015,"claim":"Active-site subsite mapping and a high-resolution zymogen structure provided the biochemical and structural framework for selective PM4 inhibition.","evidence":"Combinatorial peptide-library profiling and inhibitor design in P. berghei; 1.5 Å crystal structure of the P. falciparum truncated zymogen","pmids":["26510189","27599854"],"confidence":"High","gaps":["Structure is of the zymogen; mature-enzyme substrate complex not captured","Selectivity data are in vitro"],"attribution":[{"species":"Plasmodium berghei","strain":""},{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"claim":"Inhibitor and drug-repurposing studies linked PM4 to the antimalarial action of specific protease inhibitors, supporting it as a druggable target.","evidence":"Low-nanomolar KNI Ki measurements with PMII-KNI crystal surrogates in P. falciparum, and pm4 knockout drug-sensitivity tests with docking in P. berghei ANKA","pmids":["29943906","30067811"],"confidence":"Medium","gaps":["PMIV inhibitor complexes not independently solved","Contribution of PM4 to lopinavir/saquinavir action only inferred from KO sensitivity"],"attribution":[{"species":"Plasmodium falciparum","strain":""},{"species":"Plasmodium berghei","strain":"ANKA"}]},{"year":2020,"claim":"Solving the activation mechanism explained how PM4 converts from inactive zymogen to mature protease under acidic vacuolar conditions.","evidence":"Multiple crystal structures, MD simulations, and biochemical activation assays defining S-shaped dimer trans-activation in P. falciparum","pmids":["32385863"],"confidence":"High","gaps":["Whether trans-activation occurs identically in the intact vacuolar complex not shown","Regulation of activation timing in vivo not addressed"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"How PM4's individual proteolytic activity is coordinated within the ~200-kDa vacuolar complex and how its blood-stage role relates mechanistically to its mosquito-stage invasion function remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Stoichiometry and regulatory role of PM4 within the hemoglobinase complex undefined","Molecular substrates in ookinete midgut invasion unknown","Direct connection between hemoglobin digestion and virulence/ECM not mechanistically established"],"attribution":[]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":["~200-kDa food-vacuole hemoglobinase complex containing PM4, falcipain 2/2', PM2, HAP, and HDP [#12]"],"partners":["FALCIPAIN 2/2' [#12]","PLASMEPSIN II [#12]","HISTO-ASPARTIC PROTEASE (HAP) [#12]","HEME DETOXIFICATION PROTEIN (HDP) [#12]","VIVAPAIN-2 AND VIVAPAIN-3 (P. VIVAX, FUNCTIONAL SYNERGY AND PROCESSING) [#10]"],"other_free_text":["Synthesized as a zymogen that forms S-shaped dimers and undergoes acid-triggered trans-activation with prosegment cleavage between monomers [#17].","PM4 is the sole food-vacuole plasmepsin in non-falciparum species and is the single vacuolar plasmepsin whose loss most reduces hemozoin in P. falciparum [#2, #7].","Non-essential in P. falciparum and P. berghei; disruption attenuates growth, reduces hemozoin, prevents experimental cerebral malaria, and induces protective immunity [#4, #8, #11].","Druggable aspartic protease target inhibited by peptidomimetic (allophenylnorstatine, oxadiazole, KNI) inhibitors and implicated in the action of retroviral protease inhibitors [#3, #6, #15, #16]."]}},"prefetch_data":{},"corpus_meta":[{"pmid":"11782538","id":"PMC_11782538","title":"Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11782538","citation_count":344,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11872398","id":"PMC_11872398","title":"Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.","date":"2001","source":"Trends in parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/11872398","citation_count":252,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23471987","id":"PMC_23471987","title":"Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23471987","citation_count":130,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15491999","id":"PMC_15491999","title":"Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15491999","citation_count":103,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfPM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20019192","id":"PMC_20019192","title":"Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.","date":"2009","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20019192","citation_count":96,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12859191","id":"PMC_12859191","title":"High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor.","date":"2003","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12859191","citation_count":84,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17581121","id":"PMC_17581121","title":"Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function.","date":"2007","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/17581121","citation_count":84,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfPM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"14550891","id":"PMC_14550891","title":"Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man.","date":"2003","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/14550891","citation_count":66,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfPM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"11904142","id":"PMC_11904142","title":"Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite, Plasmodium falciparum.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11904142","citation_count":53,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17207486","id":"PMC_17207486","title":"Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum.","date":"2006","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/17207486","citation_count":45,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfPM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20043183","id":"PMC_20043183","title":"Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum.","date":"2009","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/20043183","citation_count":26,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20056606","id":"PMC_20056606","title":"Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20056606","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16939205","id":"PMC_16939205","title":"Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum.","date":"2006","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16939205","citation_count":22,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"22355558","id":"PMC_22355558","title":"Disruption of plasmepsin-4 and merozoites surface protein-7 genes in Plasmodium berghei induces combined virulence-attenuated phenotype.","date":"2011","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/22355558","citation_count":21,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19635672","id":"PMC_19635672","title":"alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases.","date":"2009","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19635672","citation_count":19,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PM4","plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17045991","id":"PMC_17045991","title":"Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor.","date":"2006","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17045991","citation_count":17,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"27982302","id":"PMC_27982302","title":"Successful application of virtual screening and molecular dynamics simulations against antimalarial molecular targets.","date":"2016","source":"Memorias do Instituto Oswaldo Cruz","url":"https://pubmed.ncbi.nlm.nih.gov/27982302","citation_count":13,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"36443817","id":"PMC_36443817","title":"Drug resistance of Plasmodium falciparum and Plasmodium vivax isolates in Indonesia.","date":"2022","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/36443817","citation_count":12,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PvPM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21334328","id":"PMC_21334328","title":"Plasmodium vivax: collaborative roles for plasmepsin 4 and vivapains in hemoglobin hydrolysis.","date":"2011","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/21334328","citation_count":12,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PvPM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"30067811","id":"PMC_30067811","title":"Deciphering the targets of retroviral protease inhibitors in Plasmodium berghei.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30067811","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21382523","id":"PMC_21382523","title":"Sequence homology and structural analysis of plasmepsin 4 isolated from Indian Plasmodium vivax isolates.","date":"2011","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/21382523","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PM4","PvPM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29943906","id":"PMC_29943906","title":"Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights.","date":"2018","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/29943906","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15181345","id":"PMC_15181345","title":"Aspartic proteases of Plasmodium vivax are highly conserved in wild isolates.","date":"2004","source":"The Korean journal of parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/15181345","citation_count":8,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PvPM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"27599854","id":"PMC_27599854","title":"Crystal structure of Plasmodium falciparum proplasmepsin IV: the plasticity of proplasmepsins.","date":"2016","source":"Acta crystallographica. Section F, Structural biology communications","url":"https://pubmed.ncbi.nlm.nih.gov/27599854","citation_count":6,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17627598","id":"PMC_17627598","title":"Mapping selectivity and specificity of active site of plasmepsins from Plasmodium falciparum using molecular interaction field approach.","date":"2007","source":"Protein and peptide letters","url":"https://pubmed.ncbi.nlm.nih.gov/17627598","citation_count":6,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18991760","id":"PMC_18991760","title":"Targeting the plasmepsin 4 orthologs of Plasmodium sp. with \"double drug\" inhibitors.","date":"2008","source":"Protein and peptide letters","url":"https://pubmed.ncbi.nlm.nih.gov/18991760","citation_count":5,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"26510189","id":"PMC_26510189","title":"Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium berghei.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26510189","citation_count":3,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PbPM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"30940150","id":"PMC_30940150","title":"Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia.","date":"2019","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/30940150","citation_count":3,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PvPM4"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32385863","id":"PMC_32385863","title":"Activation mechanism of plasmepsins, pepsin-like aspartic proteases from Plasmodium, follows a unique trans-activation pathway.","date":"2020","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/32385863","citation_count":2,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"40945876","id":"PMC_40945876","title":"Characterization of genes involved in hemoglobin degradation in Plasmodium vivax isolates from Chennai, India, and species of non-human primate malaria.","date":"2025","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/40945876","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["plasmepsin IV"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":17403,"output_tokens":5236,"usd":0.065375,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11970,"output_tokens":4823,"usd":0.090213,"stage2_stop_reason":"end_turn"},"total_usd":0.155588,"stage1_batch_id":"msgbatch_011BPjN2BL33F8cJXD1r7V7T","stage2_batch_id":"msgbatch_01Qwg6vP7qxkpL6Gsc7tajsb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"PM4 (PF3D7_1407800) is expressed during the hemoglobin-degrading intraerythrocytic stage and its protein product localizes to the food vacuole of P. falciparum, where it functions as one of four active hemoglobin-degrading aspartic proteases (alongside PM I, PM II, and HAP).\",\n      \"method\": \"Genome-wide expression analysis, food vacuole fractionation, functional enzymatic assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct subcellular fractionation combined with enzymatic activity assays; replicated by multiple subsequent studies\",\n      \"pmids\": [\"11782538\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Recombinant PM4 hydrolyzes human hemoglobin at the primary cleavage site known to initiate the hemoglobin degradation pathway, and its activity is inhibited in vitro by synthetic peptidomimetic inhibitors that also block parasite growth in red blood cell culture.\",\n      \"method\": \"In vitro enzyme activity assay with native and denatured hemoglobin substrate; inhibitor Ki measurement\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro enzymatic reconstitution with substrate and inhibitor characterization in a single focused study\",\n      \"pmids\": [\"11904142\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PM4 from P. falciparum and its orthologs from other Plasmodium species (P. vivax, P. knowlesi, P. berghei, P. yoelii, P. ovale, P. malariae) all localize to purified food vacuole preparations; PM4 is the sole food-vacuole plasmepsin in non-falciparum species, whereas P. falciparum has three paralogs (PM1, PM2, HAP) in addition to PM4. Localization was confirmed by 2D gel electrophoresis and mass spectrometry of purified food vacuole fractions.\",\n      \"method\": \"Two-dimensional gel electrophoresis and mass spectrometry of purified food vacuole preparations; genomic DNA blot analysis\",\n      \"journal\": \"Molecular and biochemical parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct fractionation with orthogonal proteomics identification, multi-species confirmation\",\n      \"pmids\": [\"14550891\"],\n      \"is_preprint\": false,\n      \"attribution\": [\n        {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium vivax\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium knowlesi\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium berghei\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium yoelii\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium ovale\", \"strain\": \"\"},\n        {\"species\": \"Plasmodium malariae\", \"strain\": \"\"}\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A designed adaptive inhibitor targeting the plasmepsin family inhibits PM4 with a Ki of ~0.2 nM (Ki ratio relative to PM II = 0.4), demonstrating that PM4's active site can accommodate the allophenylnorstatine scaffold with near-equal or greater potency than PM II.\",\n      \"method\": \"In vitro enzyme inhibition assay (Ki measurement); isothermal titration calorimetry\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous in vitro binding and inhibition assay, single study\",\n      \"pmids\": [\"12859191\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Genetic disruption of pfpm4 in P. falciparum is achievable (gene is not essential), but Δpfpm4 parasites show a reduced growth rate and a statistically significant reduction in hemozoin accumulation per parasite, indicating impaired hemoglobin digestion. An accumulation of electron-dense vesicles in the digestive vacuole was also observed in ~one-third of disrupted cells.\",\n      \"method\": \"Gene knockout by homologous recombination; PCR, Southern, Northern, Western blot confirmation; growth rate measurement; hemozoin quantification; electron microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean gene disruption confirmed by multiple molecular methods, specific cellular phenotype readouts, replicated in subsequent studies\",\n      \"pmids\": [\"15491999\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"Dd2\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Loss of all four digestive vacuole plasmepsins (including PM4) in a quadruple-PM knockout results in slower growth, delayed schizont maturation, reduced hemozoin formation, accumulation of multilamellar ceroid-like bodies in the digestive vacuole, and accumulation of autophagic intermediates, establishing that PM4 contributes (along with PM1, PM2, HAP) to degradation of endosomal vesicles delivered to the digestive vacuole.\",\n      \"method\": \"Double-crossover chromosomal deletion knockout; growth assays; electron microscopy; Western blot for autophagic markers; hemozoin measurement\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — quadruple KO with multiple orthogonal phenotypic readouts, clearly implicating PM4 as part of the DV protease ensemble\",\n      \"pmids\": [\"17581121\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"3D7\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Crystal structure of PM4 from P. falciparum complexed with inhibitors was used (via homology model and molecular dynamics) to define the binding pocket geometry; key variable regions distinguishing PM4 from PM II were identified, and a symmetric oxadiazole-containing inhibitor was identified as the most potent PM4 binder.\",\n      \"method\": \"Crystal structure determination; molecular dynamics simulation; linear interaction energy (LIE) calculations; in vitro Ki measurement\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — structural and MD data with experimental Ki validation, single study; homology model rather than de novo PM4 crystal structure used\",\n      \"pmids\": [\"16939205\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Δpfpm4 single-knockout parasites (but not Δpfpm1 or Δpfpm2 single-knockouts) show a statistically significant reduction in hemozoin accumulation per parasite cycle, establishing PM4 as the individual digestive vacuole plasmepsin with the greatest contribution to hemoglobin digestion among the four. No compensatory upregulation of paralogous plasmepsin mRNAs or proteins was detected in any single-KO.\",\n      \"method\": \"Gene disruption; hemozoin quantification; Northern blot; Western blot for paralogous plasmepsins\",\n      \"journal\": \"International journal for parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — targeted gene disruption with specific quantitative phenotype, confirmed at both mRNA and protein level, multiple KO lines compared\",\n      \"pmids\": [\"17207486\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"Dd2\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Deletion of pm4 in Plasmodium berghei significantly reduces asexual blood-stage growth rate and prevents induction of experimental cerebral malaria (ECM) in susceptible mice; Δpm4 P. berghei parasites induce strong protective immunity lasting at least one year.\",\n      \"method\": \"Gene knockout in P. berghei; in vivo mouse infection experiments; real-time in vivo parasite imaging; splenectomy experiments; antibody-depletion assays\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean gene disruption with multiple in vivo phenotypic readouts and mechanistic dissection of immunity mechanism\",\n      \"pmids\": [\"20019192\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In Plasmodium gallinaceum, the PM4 ortholog (PgPM4) is secreted by ookinetes and localizes to the ookinete apical surface and micronemes (not only the digestive vacuole); anti-PgPM4 monoclonal antibodies and aspartic protease inhibitors significantly reduce parasite infectivity for mosquitoes, implicating PM4 in ookinete invasion of the mosquito midgut.\",\n      \"method\": \"De novo mass spectrometry sequencing of benzamidine affinity column eluate; immunolocalization; infectivity assays with monoclonal antibodies and inhibitors\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS identification plus immunolocalization plus functional inhibition assays in a single study; performed in P. gallinaceum, not P. falciparum\",\n      \"pmids\": [\"20056606\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium gallinaceum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Recombinant P. vivax PM4 (PvPM4) undergoes autocatalytic maturation under acidic conditions in a pepstatin A-sensitive manner, requires a portion of the prodomain for correct folding, hydrolyzes native and denatured hemoglobin at acidic pH, and acts synergistically with vivapains (cysteine proteases) in hemoglobin hydrolysis; vivapains also mediate processing of PvPM4 into its mature form.\",\n      \"method\": \"Recombinant protein expression, refolding, and autocatalytic maturation assay; hemoglobin hydrolysis assay; synergy assay with vivapain-2 and vivapain-3; pepstatin A inhibition\",\n      \"journal\": \"Experimental parasitology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution of enzymatic activity, maturation, and synergy with multiple orthogonal assays in a single study\",\n      \"pmids\": [\"21334328\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium vivax\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Sequential disruption of both pm4 and msp7 in P. berghei produces a synergistically virulence-attenuated phenotype (self-resolving infection, low parasitemia, no ECM) greater than either single-gene deletion alone, and convalescent mice are protected against challenge with P. berghei or P. yoelii.\",\n      \"method\": \"Sequential gene disruption; in vivo mouse infection; parasitemia monitoring; cross-species challenge experiments\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis experiment demonstrating additive/synergistic effect of pm4 and msp7 deletions, single lab\",\n      \"pmids\": [\"22355558\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PM4 is a component of an approximately 200-kDa protein complex in the food vacuole that also contains falcipain 2/2', plasmepsin II, histo-aspartic protease, and heme detoxification protein (HDP); this complex is required for hemoglobin degradation and hemozoin formation.\",\n      \"method\": \"Co-immunoprecipitation followed by mass spectrometry; gel filtration co-elution; glycerol gradient cosedimentation; in vitro protein interaction analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — four orthogonal biochemical methods (Co-IP/MS, gel filtration, glycerol gradient, in vitro interaction) establishing complex membership\",\n      \"pmids\": [\"23471987\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Recombinant P. berghei PM4 (PbPM4) zymogen expressed in E. coli undergoes auto-maturation at pH 4.5–5.5 and, unusually, retains catalytic activity even in the presence of the pro-segment. Active site subsite preferences (S1, S2, S3, S1', S2', S3') were mapped using combinatorial peptide libraries, enabling design of a peptidomimetic inhibitor with >10-fold selectivity for PM4 orthologs over human cathepsin D.\",\n      \"method\": \"Recombinant protein expression, in vitro refolding, auto-maturation assay; combinatorial peptide library substrate profiling; enzyme kinetics; inhibitor Ki measurement\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with active-site mapping by combinatorial chemistry and inhibitor design/validation, multiple orthogonal assays in one study\",\n      \"pmids\": [\"26510189\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure of truncated zymogen of PM4 from P. falciparum (pPM IV, consisting of mature enzyme plus a 47-residue prosegment) was determined at 1.5 Å resolution, revealing the characteristic bi-lobed aspartic protease fold and showing greater structural similarity to proplasmepsin IV from P. vivax than to the other two P. falciparum proplasmepsins (proplasmepsin I and proplasmepsin II).\",\n      \"method\": \"X-ray crystallography at 1.5 Å resolution\",\n      \"journal\": \"Acta crystallographica. Section F, Structural biology communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — high-resolution crystal structure, single study but direct structural determination of the query gene product\",\n      \"pmids\": [\"27599854\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"KNI peptidomimetic inhibitors (KNI-10742, 10743, 10395, 10333, 10343) inhibit PM4 (PMIV) activity with low-nanomolar Ki values. High-resolution crystal structures of PMII-KNI inhibitor complexes (used as structural surrogates to model PMIV interactions) reveal specific contacts (Asp132, Leu133, Ser134; P2/P2' positioning) that modulate differential potency across vacuolar plasmepsins.\",\n      \"method\": \"In vitro Ki measurement against PM IV; crystal structures of PMII-KNI complexes at high resolution (PDB: 5YIE, 5YIB, 5YID, 5YIC, 5YIA); cellular Hb-degradation blockade assay\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — crystal structures and Ki data for PMII used to rationalize PMIV inhibition; PMIV structures not independently solved here, single lab\",\n      \"pmids\": [\"29943906\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In P. berghei, deletion of PM4 (but not PM7 or PM8) significantly reduces susceptibility to lopinavir and saquinavir (retroviral protease inhibitors) in a 4-day suppressive in vivo test, suggesting PM4 mediates at least part of the antimalarial action of these compounds.\",\n      \"method\": \"Gene knockout in P. berghei; 4-day in vivo suppressive test with lopinavir/ritonavir and saquinavir/ritonavir; molecular docking of inhibitors to PM4\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic epistasis (KO reduced drug sensitivity) with molecular docking support, single lab, single study\",\n      \"pmids\": [\"30067811\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"ANKA\"}]\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Vacuolar plasmepsin zymogens (pro-tPMs, including the PM4-family) inherently form S-shaped dimers; under acidic conditions, disruption of the Tyr-Asp loop (121p-4), coupled with movement of loop L1 (237-247) and helix H2 (101p-113p), extends the pro-mature region containing the cleavage site, dissociates dimers to monomers, and allows prosegment unfolding so that the active site becomes accessible. One monomer then cleaves the prosegment of the other via a novel trans-activation mechanism, generating mature enzyme that drives complete conversion of remaining zymogens.\",\n      \"method\": \"X-ray crystallography (PDB: 6KUB, 6KUC, 6KUD); molecular dynamics simulations; biochemical activation assays\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple crystal structures combined with MD simulations and biochemical validation of activation mechanism in a single rigorous study\",\n      \"pmids\": [\"32385863\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"PM4 (PF3D7_1407800) is an aspartic protease that is synthesized as an inactive zymogen, trafficked to the food vacuole where it undergoes acid-triggered trans-activation via an S-shaped dimer intermediate, and then functions as a hemoglobinase within a ~200-kDa multi-enzyme complex (with falcipain 2/2', PM II, HAP, and HDP) that drives hemoglobin degradation and hemozoin formation; it is the individual digestive vacuole plasmepsin that contributes most to hemozoin accumulation, and in sexual/mosquito stages its ortholog additionally localizes to ookinete micronemes and the apical surface where it participates in midgut invasion.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PM4 (PF3D7_1407800) is a food-vacuole aspartic protease that initiates and drives the intraerythrocytic hemoglobin degradation pathway of Plasmodium and thereby feeds hemozoin formation [#0, #1]. It is expressed during the hemoglobin-degrading blood stage and localizes to the food vacuole, where it acts as one of four active hemoglobinase plasmepsins in P. falciparum (with PM1, PM2, and HAP) but is the sole food-vacuole plasmepsin in other Plasmodium species [#0, #2]. Recombinant PM4 hydrolyzes native and denatured hemoglobin, including cleavage at the site that initiates hemoglobin catabolism, and its activity is blocked by peptidomimetic inhibitors that also arrest parasite growth [#1, #10]. PM4 is synthesized as a zymogen that undergoes acid-triggered maturation: vacuolar plasmepsin pro-forms assemble into S-shaped dimers, and under acidic pH conformational changes at the Tyr-Asp loop, loop L1, and helix H2 dissociate the dimer and expose the cleavage site so that one monomer trans-activates the prosegment of the other [#17, #14]. Once mature, PM4 operates within an ~200-kDa food-vacuole complex containing falcipain 2/2', PM2, HAP, and the heme detoxification protein HDP that couples hemoglobin proteolysis to hemozoin formation [#12]. Genetic disruption studies establish PM4 as functionally important but non-essential: Δpfpm4 parasites grow more slowly and, among the single food-vacuole plasmepsin knockouts, show the greatest reduction in hemozoin accumulation without compensatory paralog upregulation [#4, #7]. In P. berghei, pm4 deletion attenuates blood-stage growth and prevents experimental cerebral malaria while conferring protective immunity [#8], and in the avian parasite P. gallinaceum the PM4 ortholog additionally localizes to ookinete micronemes and the apical surface and participates in mosquito midgut invasion [#9].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing where PM4 acts and what it does answered whether it is a bona fide hemoglobinase rather than merely a plasmepsin family member.\",\n      \"evidence\": \"Genome-wide expression, food-vacuole fractionation, and enzymatic assays in P. falciparum, plus recombinant hemoglobin hydrolysis and inhibitor assays\",\n      \"pmids\": [\"11782538\", \"11904142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of PM4 versus the other three vacuolar plasmepsins not yet quantified\", \"In vivo cleavage kinetics on intact hemoglobin within the vacuole not resolved\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Cross-species localization defined PM4 as the conserved core food-vacuole plasmepsin, showing that non-falciparum species rely on PM4 alone whereas P. falciparum has paralog redundancy.\",\n      \"evidence\": \"2D gel electrophoresis and mass spectrometry of purified food-vacuole fractions across seven Plasmodium species; genomic DNA blot\",\n      \"pmids\": [\"14550891\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of single- versus multi-plasmepsin architecture not tested here\", \"Does not address complex membership or maturation\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}, {\"species\": \"Plasmodium vivax\", \"strain\": \"\"}, {\"species\": \"Plasmodium knowlesi\", \"strain\": \"\"}, {\"species\": \"Plasmodium berghei\", \"strain\": \"\"}, {\"species\": \"Plasmodium yoelii\", \"strain\": \"\"}, {\"species\": \"Plasmodium ovale\", \"strain\": \"\"}, {\"species\": \"Plasmodium malariae\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Gene disruption tested whether PM4 is essential and revealed a specific hemoglobin-digestion phenotype rather than lethality.\",\n      \"evidence\": \"Homologous-recombination knockout in P. falciparum Dd2 with growth, hemozoin, and EM readouts\",\n      \"pmids\": [\"15491999\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cannot exclude partial compensation by paralogs\", \"Molecular basis of the electron-dense vesicle accumulation unresolved\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"Dd2\"}]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Comparing single- and quadruple-knockouts ranked PM4 as the dominant individual vacuolar plasmepsin for hemozoin production and showed the ensemble also processes endosomal cargo.\",\n      \"evidence\": \"Single and quadruple plasmepsin knockouts in P. falciparum with hemozoin quantification, Northern/Western for paralogs, EM and autophagic markers\",\n      \"pmids\": [\"17581121\", \"17207486\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which PM4 loss reduces hemozoin more than other paralogs not defined\", \"No compensatory upregulation seen, but functional overlap during infection not measured\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"3D7\"}, {\"species\": \"Plasmodium falciparum\", \"strain\": \"Dd2\"}]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Structural and inhibitor-binding characterization began to define PM4's active-site geometry and the features distinguishing it from PM2 for selective drug design.\",\n      \"evidence\": \"Crystal structure/homology model with molecular dynamics, LIE calculations, and in vitro Ki measurements\",\n      \"pmids\": [\"16939205\", \"12859191\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relied partly on homology modeling rather than de novo PM4 structure\", \"Selectivity over host aspartic proteases not established here\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery of a secreted, apically localized PM4 in ookinetes extended its role beyond the food vacuole to mosquito-stage invasion.\",\n      \"evidence\": \"De novo MS sequencing, immunolocalization, and infectivity blockade with monoclonal antibodies and inhibitors in P. gallinaceum\",\n      \"pmids\": [\"20056606\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Shown in P. gallinaceum, not P. falciparum\", \"Molecular substrate mediating midgut invasion not identified\"],\n      \"attribution\": [{\"species\": \"Plasmodium gallinaceum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Reconstitution of recombinant PM4 established acid-triggered autocatalytic maturation and cooperative hemoglobin digestion with cysteine proteases.\",\n      \"evidence\": \"Recombinant expression, refolding, autocatalytic maturation, hemoglobin hydrolysis, and synergy assays with vivapains in P. vivax\",\n      \"pmids\": [\"21334328\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural intermediate of maturation not resolved in this study\", \"In vivo relevance of vivapain-mediated PM4 processing not tested\"],\n      \"attribution\": [{\"species\": \"Plasmodium vivax\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Genetic epistasis with msp7 in P. berghei defined PM4 as a virulence determinant whose loss can be combined to attenuate infection and elicit cross-protective immunity.\",\n      \"evidence\": \"Sequential gene disruption, in vivo parasitemia monitoring, and cross-species challenge in P. berghei\",\n      \"pmids\": [\"22355558\", \"20019192\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic link between PM4 loss and reduced virulence not molecularly defined\", \"Single-lab in vivo studies\"],\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Active-site subsite mapping and a high-resolution zymogen structure provided the biochemical and structural framework for selective PM4 inhibition.\",\n      \"evidence\": \"Combinatorial peptide-library profiling and inhibitor design in P. berghei; 1.5 Å crystal structure of the P. falciparum truncated zymogen\",\n      \"pmids\": [\"26510189\", \"27599854\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure is of the zymogen; mature-enzyme substrate complex not captured\", \"Selectivity data are in vitro\"],\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}, {\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Inhibitor and drug-repurposing studies linked PM4 to the antimalarial action of specific protease inhibitors, supporting it as a druggable target.\",\n      \"evidence\": \"Low-nanomolar KNI Ki measurements with PMII-KNI crystal surrogates in P. falciparum, and pm4 knockout drug-sensitivity tests with docking in P. berghei ANKA\",\n      \"pmids\": [\"29943906\", \"30067811\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"PMIV inhibitor complexes not independently solved\", \"Contribution of PM4 to lopinavir/saquinavir action only inferred from KO sensitivity\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}, {\"species\": \"Plasmodium berghei\", \"strain\": \"ANKA\"}]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Solving the activation mechanism explained how PM4 converts from inactive zymogen to mature protease under acidic vacuolar conditions.\",\n      \"evidence\": \"Multiple crystal structures, MD simulations, and biochemical activation assays defining S-shaped dimer trans-activation in P. falciparum\",\n      \"pmids\": [\"32385863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether trans-activation occurs identically in the intact vacuolar complex not shown\", \"Regulation of activation timing in vivo not addressed\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PM4's individual proteolytic activity is coordinated within the ~200-kDa vacuolar complex and how its blood-stage role relates mechanistically to its mosquito-stage invasion function remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry and regulatory role of PM4 within the hemoglobinase complex undefined\", \"Molecular substrates in ookinete midgut invasion unknown\", \"Direct connection between hemoglobin digestion and virulence/ECM not mechanistically established\"],\n      \"attribution\": []\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0004190\", \"supporting_discovery_ids\": [0, 1, 10, 13]},\n      {\"term_id\": \"GO:0004175\", \"supporting_discovery_ids\": [1, 10, 13]},\n      {\"term_id\": \"GO:0016485\", \"supporting_discovery_ids\": [10, 13, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020020\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"GO:0020009\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0043312\", \"supporting_discovery_ids\": [0, 1, 4, 5, 7]},\n      {\"term_id\": \"GO:0044179\", \"supporting_discovery_ids\": [4, 7, 12]}\n    ],\n    \"complexes\": [\n      \"~200-kDa food-vacuole hemoglobinase complex containing PM4, falcipain 2/2', PM2, HAP, and HDP [#12]\"\n    ],\n    \"partners\": [\n      \"falcipain 2/2' [#12]\",\n      \"plasmepsin II [#12]\",\n      \"histo-aspartic protease (HAP) [#12]\",\n      \"heme detoxification protein (HDP) [#12]\",\n      \"vivapain-2 and vivapain-3 (P. vivax, functional synergy and processing) [#10]\"\n    ],\n    \"other_free_text\": [\n      \"Synthesized as a zymogen that forms S-shaped dimers and undergoes acid-triggered trans-activation with prosegment cleavage between monomers [#17].\",\n      \"PM4 is the sole food-vacuole plasmepsin in non-falciparum species and is the single vacuolar plasmepsin whose loss most reduces hemozoin in P. falciparum [#2, #7].\",\n      \"Non-essential in P. falciparum and P. berghei; disruption attenuates growth, reduces hemozoin, prevents experimental cerebral malaria, and induces protective immunity [#4, #8, #11].\",\n      \"Druggable aspartic protease target inhibited by peptidomimetic (allophenylnorstatine, oxadiazole, KNI) inhibitors and implicated in the action of retroviral protease inhibitors [#3, #6, #15, #16].\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_1407800","name":null,"product":"plasmepsin IV","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PbANKA","gene_id":"PBANKA_1034400","name":null,"product":"plasmepsin IV","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PkH","gene_id":"PKNH_1350300","name":null,"product":"plasmepsin IV, putative","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"PM4","evaluation":null}